News Conference News AHA 2017 Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation Yael L. Maxwell November 27, 2017
News Conference News AHA 2017 ‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry Todd Neale November 22, 2017
News Conference News AHA 2017 Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events Michael O'Riordan November 17, 2017
News Conference News AHA 2017 RE-DUAL PCI Findings Consistent Across Key Subgroups Todd Neale November 16, 2017
News Conference News AHA 2017 Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma Todd Neale November 15, 2017
News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017
News Conference News AHA 2017 GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS Yael L. Maxwell November 14, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News AHA 2017 One in Eight US Patients With MI or Stroke Under Age 65 Are Uninsured, Face Catastrophic Costs Shelley Wood November 14, 2017
News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Conference News AHA 2017 Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation Michael O'Riordan November 13, 2017
News Conference News AHA 2017 TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery Shelley Wood November 12, 2017
News Conference News AHA 2014 DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation Yael L. Maxwell November 16, 2014